The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 20, 2024
Filed:
Aug. 21, 2018
Applicant:
Plex Pharmaceuticals, Inc., San Diego, CA (US);
Inventors:
Surya Kanta De, San Diego, CA (US);
Sridhar G. Prasad, San Diego, CA (US);
Marshall C. Peterman, Oceanside, CA (US);
Assignee:
PLEX PHARMACEUTICALS, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 213/30 (2006.01); A61K 31/4184 (2006.01); A61K 47/30 (2006.01); C07C 237/22 (2006.01); C07D 209/42 (2006.01); C07D 231/56 (2006.01); C07D 235/08 (2006.01); C07D 235/10 (2006.01); C07D 235/14 (2006.01); C07D 235/30 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07D 213/30 (2013.01); A61K 47/30 (2013.01); C07C 237/22 (2013.01); C07D 209/42 (2013.01); C07D 231/56 (2013.01); C07D 235/10 (2013.01); C07D 235/14 (2013.01); C07D 235/30 (2013.01); A61K 9/0043 (2013.01);
Abstract
Provided are novel compounds of Formulas (I) and (II), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful as dual FKBP12/FKABP inhibitors. Also provided are pharmaceutical compositions comprising the novel compounds of Formulas (I) and (II) and their use in treating Parkinson's disease.